A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity

Molecular Cell
Pablo Rodriguez-VicianaFrank McCormick

Abstract

Ras family GTPases (RFGs) are known to share many regulatory and effector proteins. How signaling and biological specificity is achieved is poorly understood. Using a proteomics approach, we have identified a complex comprised of Shoc2/Sur-8 and the catalytic subunit of protein phosphatase 1 (PP1c) as a highly specific M-Ras effector. M-Ras targets Shoc2-PP1c to stimulate Raf activity by dephosphorylating the S259 inhibitory site of Raf proteins bound to other molecules of M-Ras or Ras. Therefore, distinct RFGs, through independent effectors, can regulate different steps in the activation of Raf kinases. Shoc2 function is essential for activation of the MAPK pathway by growth factors. Furthermore, in tumor cells with Ras gene mutations, inhibition of Shoc2 expression inhibits MAPK, but not PI3K activity. We propose that the Shoc2-PP1c holoenzyme provides an attractive therapeutic target for inhibition of the MAPK pathway in cancer.

References

Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·L M SelforsM J Stern
May 10, 2000·The Journal of Biological Chemistry·D AbrahamM Baccarini
Jun 22, 2002·Molecular and Cellular Biology·Yvonne LightRichard Marais
Oct 18, 2002·Experimental Hematology·Annette EhrhardtJohn W Schrader
Mar 22, 2003·Experimental Cell Research·Nadeem Moghal, Paul W Sternberg
Jun 5, 2003·Nature Reviews. Cancer·Marcos Malumbres, Mariano Barbacid
Mar 11, 2004·The Journal of Investigative Dermatology·Hensin TsaoFrank G Haluska
Apr 20, 2004·Journal of Cell Science·Michele K Dougherty, Deborah K Morrison
May 15, 2004·Molecular and Cellular Biology·Pablo Rodriguez-VicianaFrank McCormick
May 28, 2004·Nature·Mohammed TerrakRoberto Dominguez
Sep 16, 2004·Science's STKE : Signal Transduction Knowledge Environment·John Colicelli
Nov 3, 2004·Trends in Cell Biology·Gretchen A RepaskyChanning J Der
Nov 3, 2004·Nature Reviews. Molecular Cell Biology·Claudia WellbrockRichard Marais
Dec 2, 2004·Nature Reviews. Cancer·Judith S Sebolt-Leopold, Roman Herrera
Jan 25, 2005·Molecular Cell·Michele K DoughertyDeborah K Morrison
Mar 23, 2005·Current Opinion in Cell Biology·Monica Gallego, David M Virshup
Jan 28, 2006·Science·Pablo Rodriguez-VicianaKatherine A Rauen

❮ Previous
Next ❯

Citations

May 18, 2010·Investigational New Drugs·Vladimir BeljanskiCharles D Smith
Dec 20, 2012·International Journal of Hematology·Yoko Aoki, Yoichi Matsubara
May 15, 2007·Oncogene·M M McKay, D K Morrison
Jun 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Dean OrnishPeter R Carroll
Jan 7, 2010·The Journal of Biological Chemistry·Rie Matsunaga-UdagawaMichiyuki Matsuda
Oct 19, 2012·The Journal of Biological Chemistry·Fred M KaplanAndrew E Aplin
Jan 15, 2010·Molecular Biology of the Cell·Sayaka YoshikiMichiyuki Matsuda
Jan 6, 2010·Carcinogenesis·Théodora S Niault, Manuela Baccarini
Feb 18, 2010·Molecular and Cellular Biology·Vernon T PhanFrank McCormick
Jul 24, 2013·Annual Review of Genomics and Human Genetics·Katherine A Rauen
Jul 22, 2010·Molecular Syndromology·M TartagliaB D Gelb
Mar 26, 2013·The Journal of Clinical Investigation·Robert M HarmonKathleen J Green
Jul 23, 2011·Genes & Cancer·David MatallanasWalter Kolch
May 24, 2007·BMC Bioinformatics·Junior BarreraHelena Brentani
Jun 28, 2013·PloS One·Myoungkun JeoungEmilia Galperin
Apr 9, 2014·Proceedings of the National Academy of Sciences of the United States of America·Inbal RachminEhud Razin
Aug 5, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Luís Korrodi-GregórioMargarida Fardilha
Sep 8, 2010·Cellular and Molecular Life Sciences : CMLS·Christian M UdellMarc Therrien
Aug 18, 2012·Leukemia & Lymphoma·Vanessa S SilveiraLuiz Gonzaga Tone
Jun 18, 2014·FEBS Letters·Botond CsehManuela Baccarini
May 1, 2007·Expert Opinion on Therapeutic Targets·Phelps J LambertShaw M Akula
Jul 30, 2009·Expert Opinion on Therapeutic Targets·Mehtap Cakir, Ashley B Grossman
Feb 16, 2016·Cellular Signalling·Myoungkun JeoungEmilia Galperin
Mar 15, 2011·Best Practice & Research. Clinical Endocrinology & Metabolism·Marco TartagliaMartin Zenker
Dec 15, 2010·Acta histochemica·Sarah E HensonCindy S Malone
Oct 27, 2015·Nature Genetics·Rand ArafehYardena Samuels
Aug 9, 2006·International Journal of Cancer. Journal International Du Cancer·Ralf Schreck, Ulf R Rapp
Oct 21, 2010·Annals of the New York Academy of Sciences·Marco Tartaglia, Bruce D Gelb
Nov 29, 2011·Journal of Cellular Biochemistry·Ariel F CastroLawrence A Quilliam
Jan 19, 2012·Human Mutation·Giovanni Battista FerreroEnzo Medico
Jun 16, 2010·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Jing YiRener Xu
Feb 13, 2010·The EMBO Journal·Matthias DrostenMariano Barbacid
Jan 25, 2014·American Journal of Medical Genetics. Part a·Giancarlo GarganoLivia Garavelli
Nov 10, 2009·Biochemical and Biophysical Research Communications·Ho Y Poon, James C Stone
Sep 2, 2015·The Journal of Experimental Medicine·Gina J FialaWolfgang W A Schamel
Apr 8, 2015·American Journal of Medical Genetics. Part a·Livia GaravelliMarco Tartaglia
Oct 22, 2014·The FEBS Journal·Su AnTian-Rui Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

© 2022 Meta ULC. All rights reserved